Results 131 to 140 of about 207,835 (296)
Influence of Drying Technique on Physicochemical Properties of Synthetic Hydroxyapatite and Its Potential Use as a Drug Carrier. [PDF]
Materials (Basel), 2023 Niziołek K +5 more
europepmc +1 more source
Targeted Enzyme‐Responsive Drug Carriers: Studies on the Delivery of a Combination of Drugs [PDF]
, 2004 Myung‐Ryul Lee +4 more
openalex +1 more source
Molecular Oncology, EarlyView.In prostate carcinoma, lactic acid, secreted by highly glycolytic cancer‐associated fibroblasts, is imported into tumor cells through the MCT1 transporter and prevents RSL3 and erastin‐induced ferroptosis (A). Targeting of carbonic anhydrase IX/XII, the main extracellular pH regulators, in tumor and stromal cells reduces microenvironmental acidosis and
Elisa Pardella +18 more
wiley +1 more source
Beilstein Journal of NanotechnologyTheragnostic platforms, which integrate therapeutic and diagnostic capabilities, have gained significant interest in drug research because of to their potential advantages.
Thi Ngoc Han Pham +7 more
doaj +1 more source
Evaluation of drug carrier hepatotoxicity using primary cell culture models. [PDF]
Nanomedicine, 2023 Kibar G, Dutta S, Rege K, Usta OB.
europepmc +1 more source
β‐TrCP overexpression enhances cisplatin sensitivity by depleting BRCA1
Molecular Oncology, EarlyView.Low levels of β‐TrCP (Panel A) allow the accumulation of BRCA1 and CtIP, which facilitate the repair of cisplatin‐induced DNA damage via homologous recombination (HR) and promote tumor cell survival. In contrast, high β‐TrCP expression (Panel B) leads to BRCA1 and CtIP degradation, impairing HR repair, resulting in persistent DNA damage and apoptosis ...
Rocío Jiménez‐Guerrero +8 more
wiley +1 more source
Chitosan-Coated MIL-100(Fe) as an Anticancer Drug Carrier: Theoretical and Experimental Investigation. [PDF]
ACS Med Chem Lett, 2023 Tohidi S, Aghaie-Khafri M.
europepmc +1 more source